Nationwide Survey of 741 Patients with Systemic Amyloid Light-chain Amyloidosis in Japan.
Conclusion The clinical features of Japanese patients with systemic AL amyloidosis are similar to those reported previously for cases in the US and Europe. Regarding treatment, a significant number of ASCTs were performed in Japan as well as in Western countries. Surprisingly, a marked number of patients received bortezomib as a treatment for AL amyloidosis.
PMID: 29093404 [PubMed - as supplied by publisher]
Source: Internal Medicine - Category: Internal Medicine Tags: Intern Med Source Type: research
More News: Amyloidosis | Bone Marrow Aspiration and Biopsy | Cardiology | Gastroenterology | Heart | Heart Transplant | Internal Medicine | Japan Health | Kidney Transplant | Kidney Transplantation | Liver | Liver Transplant | Stem Cell Therapy | Stem Cells | Study | Transplants | Urology & Nephrology | Velcade | Women